US 2025/0352570 A1Published application

Methods for treating myeloid malignancies

AssigneeGammaDelta Therapeutics Ltd

InventorsAndre Goncalo Do Espirito Santo SIMOES, Biagio Di LORENZO, Michael KOSLOWSKI, Bruno Miguel De Carvalho E SILVA SANTOS, Andrew John HUTTON, Timothy Joel RECALDIN, Daniel FOWLER, Alice BROMLEY, Oliver NUSSBAUMER

Life of this patent

Estimating the term…

Abstract

The invention relates to methods of treating myeloid malignancies by administering compositions comprising Vδ1+ T cells.

Claims23

Dependent claims

A method of treating a myeloid malignancy comprising administering a therapeutically effective amount of an allogeneic composition comprising Vδ1+ T cells to a patient with said myeloid malignancy.

Dependencies are inferred from the claim text.

Facts

Application: 19/187,851Filed 23 Apr 2025
Priority: 20 Mar 2020
Published: 20 Nov 2025
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/7076
Containing condensed or non-condensed pyrimidines: containing purines, e.g. adenosine, adenylic acid
A61K 31/675
Phosphorus compounds: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
A61K 40/11
Characterised by the cell type used: t-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer…
A61K 40/42
Vertebrate antigens: cancer antigens

Family

Application62/992,791Us provisional application · filed 20 Mar 2020
Application17/207,431Continuation · filed 19 Mar 2021
Application18/472,112Continuation · filed 21 Sep 2023
Application19/187,851Continuation
US 2021/0290674 A1Published application
US 2024/0082308 A1Published application
US 2025/0352570 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results